Akira Taguchi Selected Research

Bone Density Conservation Agents

1/2022	Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".
6/2017	Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries.
1/2017	Erratum to: Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.
1/2017	Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.
1/2016	Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw.
12/2015	Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Taguchi Research Topics

Disease

19	Osteoporosis 12/2021 - 12/2004
12	Neoplasms (Cancer) 01/2022 - 07/2010
9	Osteonecrosis (Kienbock's Disease) 01/2022 - 12/2015
5	Tooth Loss 09/2022 - 05/2003
4	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 01/2021
4	Periodontal Diseases (Periodontal Disease) 01/2022 - 01/2017
3	Hemorrhage 02/2022 - 03/2005
3	Glioma (Gliomas) 02/2022 - 09/2019
3	Diabetes Mellitus 05/2019 - 02/2011
2	Diffuse Intrinsic Pontine Glioma 02/2022 - 01/2021
2	Hyperplasia 01/2022 - 12/2020
2	Cavernous Hemangioma (Cavernous Angioma) 01/2022 - 12/2020
2	Hematoma 01/2022 - 12/2020
2	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2019
2	Hydrocephalus (Hydrocephaly) 01/2022 - 09/2019
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 03/2021 - 02/2020
2	Edema (Dropsy) 01/2021 - 11/2019
2	Osteoporotic Fractures 11/2020 - 06/2017
2	Bone Resorption 06/2019 - 12/2015
2	Hypertension (High Blood Pressure) 05/2019 - 02/2008
2	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2010
2	Kyphosis 11/2016 - 01/2016
2	Periodontitis 10/2009 - 02/2008
1	Mycoses (Diseases, Fungus) 01/2022
1	Alveolar Bone Loss 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Germinoma 03/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Acromegaly 01/2021
1	Adenoma (Adenomas) 01/2021
1	Stress Fractures (Stress Fracture) 01/2021
1	Osteomyelitis 05/2020
1	Teratoma (Teratoid Tumor) 02/2020
1	Cysts 11/2019
1	Hypersensitivity (Allergy) 09/2019
1	Hypocalcemia 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Confusion (Bewilderment) 06/2017
1	Periapical Diseases 01/2017

Drug/Important Bio-Agent (IBA)

10	Diphosphonates (Bisphosphonates)IBA 09/2019 - 07/2010
6	Bone Density Conservation AgentsIBA 01/2022 - 12/2015
6	Denosumab FDA Link 01/2021 - 12/2015
4	Estrogens (Estrogen)FDA Link 01/2018 - 05/2003
3	GadoliniumIBA 02/2022 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 02/2008
3	Raloxifene Hydrochloride (Evista)FDA Link 11/2020 - 05/2019
3	AcidsIBA 11/2020 - 05/2019
2	dipinacoline glutamateIBA 02/2022 - 01/2021
2	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2021
2	Capsules (Microcapsules)IBA 01/2022 - 12/2020
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2021 - 01/2021
2	Thyroid HormonesIBA 07/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 02/2020 - 12/2015
2	Bevacizumab (Avastin)FDA Link 01/2020 - 11/2019
2	Collagen Type I (Type I Collagen)IBA 06/2019 - 12/2015
2	eldecalcitol (ED 71)IBA 06/2019 - 12/2015
2	Vitamin D FDA LinkGeneric 01/2018 - 12/2015
2	Teriparatide (Parathar)FDA Link 01/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2015
2	MineralsIBA 07/2010 - 03/2005
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2009 - 02/2008
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2009 - 02/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2009 - 02/2008
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2004 - 06/2004
2	Estrogen ReceptorsIBA 05/2003 - 05/2003
1	pentosidineIBA 09/2022
1	HomocysteineIBA 09/2022
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2021
1	YM 529IBA 11/2020
1	CR 6IBA 11/2019
1	Zoledronic Acid (Zometa)FDA Link 11/2019
1	Carboplatin (JM8)FDA LinkGeneric 09/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 09/2019
1	Alkaline PhosphataseIBA 06/2019
1	25-hydroxyvitamin DIBA 05/2019
1	CalciumIBA 01/2018
1	Aromatase InhibitorsIBA 01/2018
1	ORALIT (ORS)IBA 01/2016
1	collagen type I trimeric cross-linked peptideIBA 12/2015
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2015

Therapy/Procedure

11	Therapeutics 01/2022 - 08/2005
6	Tooth Extraction (Tooth Extractions) 05/2020 - 12/2015
3	Drug Therapy (Chemotherapy) 03/2021 - 09/2019
3	Oral Hygiene (Dental Hygiene) 11/2019 - 01/2015
3	Oral Surgery (Maxillofacial Surgery) 01/2017 - 07/2010
2	Radiotherapy 03/2021 - 01/2021
1	Ventriculostomy 01/2022
1	Chemoradiotherapy 02/2020
1	Neoadjuvant Therapy 02/2020
1	Oral Surgical Procedures 06/2017
1	Contraindications 01/2017